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https://doi.org/10.1016/j.stem.2018.09.008SUMMARY
A broad molecular framework of how neural stem
cells are specified toward astrocyte fate during brain
development has proven elusive. Here we perform
comprehensive and integrated transcriptomic and
epigenomic analyses to delineate gene regulatory
programs that drive the developmental trajectory
from mouse embryonic stem cells to astrocytes. We
reportmolecularlydistinctphasesof astrogliogenesis
that exhibit stage- and lineage-specific transcrip-
tomic and epigenetic signatures with unique primed
and active chromatin regions, thereby revealing regu-
latory elements and transcriptional programs under-
lying astrocytegeneration andmaturation.By search-
ing for transcription factors that function at these
elements, we identified NFIA and ATF3 as drivers of
astrocyte differentiation from neural precursor cells
while RUNX2 promotes astrocyte maturation. These
transcription factors facilitate stage-specific gene
expression programs by switching the chromatin
state of their target regulatory elements from primed
to active. Altogether, these findings provide inte-
grated insights into the genetic and epigeneticmech-
anisms steering the trajectory of astrogliogenesis.
INTRODUCTION
A comprehensive understanding of the molecular mechanisms
underlying cellular diversity and cell-fate specification duringCell Stem Cell 23, 557–571, Oc
This is an open access article undCNS development remains elusive. In the developing CNS, neu-
ral precursor cells (NPCs) are known to give rise first to neurons
and then to glia such as astrocytes and oligodendrocytes (Krieg-
stein and Alvarez-Buylla, 2009). The molecular circuitry underly-
ing the differentiation of NPCs into astrocytes is only beginning to
be untangled. Astrocytes are involved in various functions that
are important for the establishment, maintenance, and plasticity
of the brain (Tiwari and Berninger, 2017). Because of these
important roles, malfunctions in astrocytes have been implicated
in many neurological diseases (Molofsky et al., 2012).
Despite these advances, the gene regulatorymechanisms that
control the differentiation and maturation of astrocytes from
NPCs, hereafter referred to as astrogliogenesis, remain to be un-
covered. A plethora of signaling pathways are known to play a
critical role in the differentiation of NPCs into astrocytes (Kanski
et al., 2014). For instance, BMP2 promotes STAT3-mediated as-
trogliogenesis by forming a STAT3-SMAD1-p300 co-activating
complex that initiates expression of astrocyte-specific genes
by binding to their promoters (Fukuda et al., 2007; Nakashima
et al., 1999). In addition to STAT3 (Bonni et al., 1997; Moon
et al., 2002), several other transcription factors (TFs), including
SOX9, NFIA (Kang et al., 2012), ETV5/ERM (Li et al., 2012), and
ZBTB20 (Nagao et al., 2016), have been implicated as important
in astrogliogenesis. Emerging evidence implies that these TFs
interplay with epigenetic mechanisms to regulate astrocyte-
specific genes. At the onset of astrogliogenesis, STAT3 binds
to the Gfap promoter and promotes DNA demethylation, result-
ing in gfap expression (Fan et al., 2005). Similarly, NOTCH
signaling induces the expression of Nfia in neural progenitor
cells, which then targets the promoters of astrocyte-specific
genes and causes DNA demethylation at these promoters by
displacing DNMT1 (Namihira et al., 2009). Furthermore, at the
onset of gliogenesis, the Polycomb group (PcG) proteins represstober 4, 2018 ª 2018 The Author(s). Published by Elsevier Inc. 557
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
pro-neuronal genes, such as Neurog1, thereby restricting the
neurogenic competence of NPCs (Hirabayashi et al., 2009).
Finally, proteins of the high-mobility group nucleosome-binding
family, HMGN1, HMGN2, and HMGN3, also play a critical role
in promoting differentiation of astrocytes (Nagao et al., 2014).
Despite these exciting advances, a comprehensive understand-
ing of the transcriptional and epigenetic mechanisms acting
along the differentiation trajectory from NPCs to astrocytes re-
mains elusive. In addition, although the enhancers have a known
role in cell-fate specification (Buecker et al., 2014), no studies
have performed an in-depth investigation to identify the regula-
tory elements that are involved in defining the distinct phases
of astrogliogenesis and the epigenetic mechanisms and TFs
that operate at these sites during this process.
Here we used amodel of astrogliogenesis frommouse embry-
onic stem cells in combination with next-generation sequencing
and computational approaches to pinpoint distinct stages
along the differentiation trajectory by identifying stage-specific
transcriptional programs and epigenetic states. This quest al-
lowed us to discern stage- and lineage-specific regulatory ele-
ments that represent putative targets of the TFs Nfia, Atf3,
and Runx2.
RESULTS
Distinct Gene Expression and Epigenetic Landscape
Define Stages of Astrogliogenesis
To investigate the gene regulatory mechanism underlying astro-
gliogenesis, we first adapted an experimental model that uses
mouse embryonic stem cells (ESCs) to generate highly enriched
astrogliogenic neural precursor cells (aNPCs) that subsequently
differentiate into astrocytes (early astrocyte [eA] and mature or
late astrocyte [lA]) (Figure 1A; Figure S1A) (Conti et al., 2005;
Pollard et al., 2006). qRT-PCR and immunoblot analyses showed
that these astrocytes express established markers (e.g., Gfap,
S100b, Nfia, Glast, Aqp4, and Cx43) (Figures S1B and S1C; Fig-
ure 1A). Using markers for neuronal cells (TUBB3 and DCX) and
progenitor cells (NES, OLIG2, and ASCL1), we found that these
cultures exhibit a minimal presence of these cells (Figure S1D).
However, we observed differences in the expression levels of
AQP4, GLAST, and CX43, indicative of astroglial heterogeneity
(Figure S1D). The differentiation of aNPCs into astrocytes was
accompanied by a cessation of cell proliferation (Figure S1E).
Furthermore, we found that similar to astrocytes in vivo, mature
astrocytes generated calcium signals upon mechanical stimula-
tion that propagated to neighboring astrocytes, indicative of their
functional maturation (Figures S1F and S1G). In line with previ-
ous studies, aNPCs were able to generate neurons when
leukemia inhibitory factor (LIF) and fetal bovine serum (FBS)
were withdrawn from the differentiation medium (Figure S1H)
(Conti et al., 2005; Pollard et al., 2006).
To measure the global gene expression changes that accom-
pany astrogliogenesis, we performed high-coverage transcrip-
tome profiling (RNA sequencing [RNA-seq]) of ESCs, aNPCs,
and astrocytes at various stages of differentiation, spanning
the early and later phases (1, 5, and 21 days, hereafter referred
as eA, lA_1, and lA_2, respectively). A principal-component
analysis (PCA) of the transcriptome datasets uncovered a
progressive separation of the transcription profiles during astro-558 Cell Stem Cell 23, 557–571, October 4, 2018gliogenesis, suggesting that the acquisition of distinct gene
expression programs gave rise to stage-specific cellular identity
(Figure 1B). The differential expression analysis of the contig-
uous stages of astrogliogenesis revealed major differences
among the early stages, while the stages lA_1 and lA_2 were
transcriptionally similar, indicating that terminal astroglial gene
expression was largely established at lA_1 (Figure 1B). Thus, in
the subsequent analysis, we focused on themature or late astro-
cytes, hereafter referred to as lA. We then identified genes that
were differentially expressed using pairwise comparisons of
subsequent stages during astrogliogenesis (Figure S1I; Table
S1) and grouped them into five clusters (Figure 1C; Table S2),
in temporal order, according to their expression kinetics during
astroglial differentiation. Moreover, genes that were highly ex-
pressed during astrogliogenesis from mouse ESCs were highly
expressed in astrocytes in vivo (Cahoy et al., 2008; Zhang
et al., 2016) and at higher levels than those found in neurons (Fig-
ure 1C). This analysis showed progressive changes in the
expression profiles and reflected the developmental trajectory
as supported by gene ontology (GO) term analysis of these
gene clusters, showing enrichment of stage-relevant biological
pathways (Table S2). Cluster 1 (ESC genes) and cluster 2
(ESC/aNPC genes) were enriched with genes involved in cell-
cycle andmetabolic pathways, reflecting the proliferative activity
of these cell types and the associated high metabolic rate (Table
S2; Figure 1C; Figures S1J and S1K). Cluster 3 (aNPC/eA) and
cluster 4 (eA) showed enrichment with genes involved in nervous
system development, reflecting the ongoing process of astro-
gliogenesis (Table S2; Figure 1C; Figures S1L and S1M).
Cluster 5 (lA_1 and lA_2) was enriched with GO terms such as
signaling and cytokine response, which are features that have
been linked to mature astrocytes (Michelucci et al., 2016) (Table
S2; Figure 1C; Figure S1N). Consistent with the progressive dif-
ferentiation and maturation of astrocytes, we found that Gfap
was induced at the onset of astroglial differentiation (eA), while
the maturation marker Aqp4 only appeared during later stages
(Figure 1D). In contrast, the mature neuronal marker Rbfox3
was never expressed during astrogliogenesis (Figure 1D). In
addition, a comparison of our datasets with the astrocyte gene
expression data retrieved from Network Glia (http://www.
networkglia.eu), which includes published datasets (Cahoy
et al., 2008), revealed similar expression kinetics in signature
genes of in vivo- and in vitro-differentiated astrocytes (Fig-
ure S1O). Altogether, these features confirm that our in vitro
astrogliogenesis model is highly suitable for studying gene regu-
latory mechanisms underlying astrocyte differentiation. Further-
more, our observations clearly highlight that the consecutive
stages of astrogliogenesis can be defined by distinct gene
expression profiles.
Acetylation of lysine 27 at histone H3 (H3K27ac) marks active
proximal and distal regulatory elements (Creyghton et al., 2010;
Shlyueva et al., 2014). To identify these regulatory regions, we
generated H3K27ac chromatin immunoprecipitation sequencing
(ChIP-seq) profiles during the stages of astrogliogenesis (aNPC,
eA, and lA) (Figure S1P). Single-gene visualizations showed an
expected enrichment in H3K27ac levels at astroglial genes
(e.g., Gfap and Aqp4), while neuronal genes (e.g., Rbfox3) failed
to show enrichment of this mark during astrogliogenesis (Fig-
ure 1E). Although the total number of H3K27ac-enriched sites
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Figure 1. Distinct Gene Expression Programs and Distal Epigenetic Footprints Define Distinct Stages of Astrogliogenesis
(A) Schematic representation of astroglial differentiation from ESCs. Immunofluorescence staining of DAPI and GFAP in the ESC-derived astrocytes during
phases of astrogliogenesis, including aNPC, eA, lA_1, and lA_2. Scale bar is 100 mm.
(B) Principal-component analysis plot depicting the distribution of the transcriptomes of ESC (pink), aNPC (light blue), eA (dark blue), and two stages of lA (shades
of green) within the scope of the first two components after RNA-seq in these stages. The x and y axes show the percentage of variance explained by the first 2
principal components.
(C) Left side: clustered heatmap depicting the expression of differentially expressed genes during any stage of the in vitro astroglial differentiation, along with the
names of known key genes in each of these clusters. Expression in the heatmap is scaled from blue (lowest) to red (highest). Right side: locally weighted
scatterplot smoothing (lowess) regression line for these clusters in the same order as the published astrocyte transcriptomes by Cahoy et al. (2008) and Zhang
et al. (2016).
(D and E) University of California Santa Cruz (UCSC) browser track example of expression (D) and H3K27ac enrichment (E) at the astroglial genes, i.e., Gfap and
Aqp4, and the neuronal gene Rbfox3 during the stages of the in vitro astroglial differentiation (ESC, aNPC, eA, and lA).
(F) Stacked-bar plot depicting the number of common and unique (across astroglial differentiation) H3K27ac peaks under each condition of astroglial differ-
entiation sorted by their genomic location, i.e., intergenic, promoter, exon, and intron.
(G) Venn diagram representing the overlap of the H3K27ac peaks within a distance of 50 kb from the nearest genes called in aNPC, eA, and lA.
(H) Boxplot representing the expression of the genes, as determined as log2-normalized read counts, that are associated with the aNPC, eA, and lA unique
H3K27ac peaks depicted in (G).
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remained in the same range for all stages, they exhibited a sub-
stantial number of uniquely acquired H3K27ac-enriched regions.
These uniquely enriched sites were particularly conspicuous at
the aNPC and lA stages, whereas astrocytes at the eA stage
showed far fewer unique H3K27ac-enriched sites, possibly re-
flecting an intermediate epigenetic profile at this transitory stage
(Figures S1Q and S1R).
The genomic distribution of H3K27ac-enriched sites revealed
its very similar occurrence at promoters and non-promoter (or
‘distal’, including intergenic, exons, and introns) regions in
aNPC, eA, and lA stages (Figure 1F). However, the stage-specific
H3K27ac sites were predominantly located in non-promoter re-
gions, except for eA (Figure 1F). We also validated that the
H3K27ac enrichment at promoter and distal regions of several
known astrocyte genes increased during astroglial differentiation
using ChIP-qPCR experiments (Figures S1S and S1T). To iden-
tify genes putatively regulated by the distal H3K27ac sites, we
assigned genes according to proximity (50 kb) to the stage-
specific distal H3K27ac sites. Although many of these sites
shared the same nearest gene, many genes were uniquely asso-
ciated with stage-specific H3K27ac-enriched sites (Figure 1G).
These non-overlapping genes were expressed at significantly
higher levels at their corresponding stages, except for the eA
stage (Figure 1H).
Epigenetic Priming Precedes Stage-Specific
Acquisition of Active Chromatin at Regulatory Regions
during Astrogliogenesis
Mono-methylation of lysine 4 at histone H3 (H3K4me1) marks
primed or active enhancers in the absence or presence of
H3K27ac, respectively (Creyghton et al., 2010). Given the critical
role of the crosstalk among various chromatin marks at regula-
tory elements in defining cell-type-specific gene expression
programs, we investigated whether H3K27ac enrichment is
related to the occurrence of H3K4me1 at these sites during
astrogliogenesis. Toward this end, we generated H3K4me1
ChIP-seq profiles during the stages of astrogliogenesis (aNPC,
eA, and lA) (Figure S2A). Further analysis revealed a substantial
number of stage-specific H3K4me1-enriched regions, which
were nearly three-fold higher in lA (Figure S2B). The genes with
H3K4me1-enriched promoters included Gfap and Aqp4, which
already exhibited high levels of H3K4me1 in aNPC before acqui-
sition of H3K27ac (Figure 1E) and transcription (Figures 2A and
2B) at the eA and lA stages, respectively, indicative of priming.
High levels of H3K4me1 were also detected at the promoters
of neurogenic genes, such as Rbfox3 in aNPC (Figure 2C). These
H3K4me1-enriched regions were not only at the promoters of
astrocyte-specific genes but also at the distal regions, as vali-
dated by ChIP-qPCR assays (Figures S2C and S2D). Astro-
cyte-specific genes were either not primed or minimally primed
in ESCs, and they acquired priming only upon commitment to
the astrocyte lineage, i.e., in astrocyte progenitor cells (aNPCs)
(Figures S2C and S2D).
We next investigated the H3K4me1 enrichment patterns at the
stage-specific H3K27ac sites during astrogliogenesis. A profile
plot depiction of these H3K27ac sites revealed their stage-spe-
cific high enrichment during astrogliogenesis (Figures 2D–2F).
The aNPC-specific H3K27ac sites showed the highest enrich-
ment of H3K4me1 at the aNPC state, and upon astrocyte differ-560 Cell Stem Cell 23, 557–571, October 4, 2018entiation, H3K27ac enrichment was lost in these regions and
H3K4me1 levels were reduced (Figures 2D and 2G). eA-specific
H3K27ac sites were already marked by H3K4me1 in aNPC, and
H3K4me1 enrichment patterns were maintained through the eA
stage while gaining H3K27ac (Figures 2E and 2H). Furthermore,
these regions lost H3K27ac at the lA stage, and the levels of
H3K4me1 were reduced. Similarly, lA-specific H3K27ac sites
gained H3K4me1 at the eA stage and increased this mark at
the lA stage (Figures 2F and 2I). These data suggest that epige-
netic priming of astroglial genes occurs before their acquisition
of an active chromatin state and transcriptional activation.
We then attempted to unravel the distinct set of genes that
show different dynamics of H3K27ac at the H3K4me1 primed
sites during astrogliogenesis versus neurogenesis and extended
these analyses to reveal the gene regulatory landscapes that
contribute to the divergence of these two lineages. Therefore,
we adapted an established system in which ESCs differentiate
into neurogenic neural precursor cells (nNPCs) and subse-
quently into terminally differentiated neurons (TNs) via different
stages (early neuron [eN] and late neuron [lN]) (Bibel et al.,
2004) (Figure S2E). Previous studies have shown distinct epige-
nomic and transcriptomic changes in this model of neurogenesis
that closely mimicked in vivo (Mohn et al., 2008; Stadler et al.,
2011; Thakurela et al., 2015). A clustering analysis of the regions
primed in aNPC produced seven sets of patterns (Figure 2J; Fig-
ure S2F; Table S3). Clusters 1, 3, and 5 showed minimal dy-
namics of H3K4me1 and H3K27ac during both astrogliogenesis
and neurogenesis. Cluster 2 represented regions primed in
aNPC that gain H3K27ac only during neurogenesis. Further anal-
ysis of cluster 2 showed that this cluster contains genes that are
specific to neuronal differentiation, such as NeuroD1, Neurog1,
and Neurog2 (Figure 2K), supporting multipotency at the aNPC
stage. Cluster 4 contained genes that are marked by H3K4me1
without subsequent enrichment of H3K27ac in either lineage.
Finally, clusters 6 and 7 contained sites that are primed in
aNPC and gain H3K27ac specifically during astrogliogenesis.
These clusters comprise astrocyte-specific genes, such as
Gfap, Aqp4, Aldh1l1, Aldoc, Cd44, and S100b (Figure 2L). The
switch from a primed to an active state is accompanied by a tran-
scriptional induction of genes in the nearest to these sites (Fig-
ure S2G). GO analysis of cluster 2 showed enrichment of genes
related to neuronal differentiation (Figure S2H), whereas cluster
6- and cluster 7-specific genes were related to cell signaling
and cell morphogenesis (Figure S2I). Furthermore, cluster 6-
and cluster 7-contained sites were primed in nNPC, eN, and
lN, whereas they never gained H3K27ac during neuronal differ-
entiation (Figures 2M and 2N). Altogether, these data reveal
epigenetic priming in regulatory elements, which precedes the
stage-specific acquisition of active chromatin and transcrip-
tional activation during astrogliogenesis.
Distinct TFs Shape the Epigenetic Landscape to
Demarcate Astrocyte versus Neuronal Fate
Prompted by our finding that these regulatory elements are
dynamically used during astrogliogenesis, we were interested
in identifying TFs that function at these elements and how they
differ from the factors that orchestrate neurogenesis. Using da-
tasets from the neuronal differentiation model described earlier
(Bibel et al., 2004; Thakurela et al., 2015), our analysis revealed
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Figure 2. Epigenetic Priming of Lineage- and Stage-Specific Regulatory Elements before Their Activation during Astrogliogenesis
(A–C) UCSC browser track showing H3K4me1 enrichment at the regulatory regions of astroglial genes (A: Gfap, B: Aqp4) and neuronal gene (C: Rbfox3).
(D–I) Profile plots depicting the enrichment of H3K27ac (D–F) and H3K4me1 (G–I) at the aNPC (D and G), eA (E and H), and lA (F and I) unique H3K27ac peaks.
(J) Unsupervised clustering-based heatmap depicting the ChIP-seq enrichment of H3K4me1 during all stages of astrogliogenesis and H3K27ac during all stages
of astrogliogenesis and neurogenesis at the H3K4me1 peaks in aNPC.
(K and L) Line plot depicting the enrichment of H3K4me1 during all stages of astrogliogenesis and H3K27ac during all stages of astrogliogenesis and neuro-
genesis in the regulatory regions of neuronal marker genes (K) and astroglial marker genes (L) that belong to clusters 2 and 6 or 7 from (J), respectively.
(M and N) H3K4me1 enrichment during neuronal differentiation at cluster 6 (M) and cluster 7 (N) sites.
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Figure 3. Distinct TFs Set Up the Active Distal Regulatory Landscape Underlying Astroglial Differentiation
(A) Workflow that includes the outline of the computational pipeline for how and which TFs were selected, as well as the follow-up experimental part, including
knockdown of these TFs and accompanied phenotypic and/or marker analysis.
(C–D) Venn diagram depicting the overlap ofmotifs that are enriched at unique H3K27ac peaks, including promoters, in aNPC and nNPC (A), eA and eN (B), and lA
and lN (C). Shown inset are two representative motifs from each set.
(E–I) Profile plots representing H3K27ac enrichment at the genomic location of the motifs of the respective TFs within the scope of the unique H3K27ac peaks in
eA (Nfia and Atf3 in E and F) and lA (Stat3, Prdm9, and Runx2 in G–I) upon depletion of TFs. The enrichment is depicted as a log two-fold change above the
genomic input.
(J–L) UCSC browser track example from (E), (F), and (I).strikingly different gene expression programs during astrocytic
differentiation compared to neuronal differentiation (Figure S3A)
and a large number of genes differentially expressed for aNPC
versus nNPC, eA versus eN, and lA versus lN (Figures S3B–
S3D). GO analysis revealed that highly induced genes in aNPC
were enriched for nervous system development, including glio-
genesis (aNPC versus nNPC) (Figure S3E). Furthermore, the
genes highly upregulated in eAs compared to eNs were enriched
for proliferation-, migration-, and cell adhesion-related genes
(Figure S3F). Finally, the genes that were more higher expressed
in lAs versus lNs were enriched with functions such as signaling
and cytokines (Figure S3G). In addition to the TFs and epigenetic
regulators (ERs) known to be relevant for astrogliogenesis, such
as Nfia (Deneen et al., 2006; Piper et al., 2010), this list contained
several TFs and ERs whose function in astrogliogenesis is un-
known (Figures S3H–S3M; Table S1).
To reveal the differential chromatin landscape during astroglial
versus neuronal differentiation, we compared the uniquely
enriched H3K27ac sites during various stages of astrogliogene-
sis to those of the corresponding stages of neurogenesis (Figure
3A; Figure S3N). This comparison revealed that stage-specific
H3K27ac-enriched regions were largely unique to this lineage562 Cell Stem Cell 23, 557–571, October 4, 2018and did not occur during neurogenesis (Figure S3N). Similar
findings were observed in comparisons with tissues from other
lineages (Figures S3O and S3P). We then investigated whether
H3K27ac-enriched genomic regions during astrogliogenesis
recruit TFs that are similar to or different from those that are
recruited during neurogenesis. Thus, we performed a motif
enrichment analysis of the unique H3K27ac peaks during each
stage of astrogliogenesis, compared these peaks with those
that occurred during the corresponding stages of neurogenesis,
and extended similar analysis to common peaks (Figure 3A).
Although several enriched TF motifs were common between
the astrogliogenesis and the neurogenesis stages, a remarkable
number of motifs were unique to the astrocyte or the neuronal
differentiation stages (Figures 3B–3D; Figure S3Q; Table S4).
These motifs included binding sites for many TFs that have
previously been shown to be critical for astrogliogenesis (e.g.,
Nfia and Runx2) and neurogenesis (e.g., Lhx2 and Brn1)
(Table S4) (Deneen et al., 2006; Dominguez et al., 2013; Okawa
et al., 2016; Subramanian et al., 2011). This analysis revealed
several additional TFs that have not been previously implicated
in astrogliogenesis and neurogenesis, thus warranting further
investigation.
TFs that function at distal regulatory elements often contribute
to the activation of these sites (Shlyueva et al., 2014; Thakurela
et al., 2015). Therefore, we investigated whether the TFs that
were predicted to be enriched at the active regulatory elements
during astrogliogenesis contribute to the active chromatin state
in these regions (Figure 3A; Figure S3Q). Thus, we performed
small interfering RNA (siRNA)-mediated depletion of selected
stage-specific TFs during the eA and lA stages and shortlisted
the TFs whose knockdown impaired the acquisition of astrocyte
markers (Figure 3A; Figures S3R–S3T). This approach led to the
identification of Nfia and Atf3 at the eA stage and Stat3, Runx2,
and Prdm9 at the lA stage of astrogliogenesis (Figure 3A; Figures
S3R–S3U).While Nfiawas expressed during each stage of astro-
glial differentiation, Atf3 and Stat3 are specifically upregulated in
eA and lA, respectively (Figures S3V and S3W). In contrast,
Runx2 (Figures S3V and S3X) and Prdm9 showed highest
expression in lA and aNPC, respectively (Figure S3V). However,
while Nfia, Atf3, and Stat3 transcription was low during neuro-
genesis, Prdm9 and Runx2 showed higher expression (Fig-
ure S3V). We then investigated whether knockdown-induced
defects in the astrocytic gene expression were due to an aber-
rant epigenetic state at the target distal regulatory elements.
Therefore, we assessed the levels of H3K27ac at putative target
sites using ChIP-seq analysis after their depletion during astro-
gliogenesis. The loss of Nfia and Atf3 in eA and the loss of
Runx2 in lA led to a reduction in the H3K27ac levels at putative
distal target sites, while the depletion of the other TFs (Stat3
and Prdm9) did not have such an effect (Figures 3E–3I). These
global observations were validated by single-locus visualizations
(Figures 3J–3L). In summary, these findings reveal lineage-spe-
cific TFs that shape the epigenetic landscape of distal regulatory
elements during astrocyte differentiation and maturation.
Stage- and Lineage-Specific Activation of Regulatory
Elements during Astrogliogenesis and Neurogenesis
Prompted by our findings that distinct TFs are required for
conferring an active chromatin state to distal regulatory ele-
ments, we next investigated the activation dynamics of the TF-
target elements during astrogliogenesis and neurogenesis by
measuring H3K27ac levels specifically at these sites. Putative
Nfia and Atf3 sites were highly enriched with H3K27ac only dur-
ing the eA stage of astrogliogenesis; these sites remained devoid
of H3K27ac during neurogenesis (Figures 4A and 4B; Figures
S4A–S4F). Conversely, a similar analysis of the eN-specific TF
Lhx2 showed that its putative target sites gain H3K27ac in eN,
but not in eA (Figure 4C; Figures S4G–S4I). The expression of
the genes nearest to these sites also tended to be higher in eA
compared to that in eN for both Nfia and Atf3, while in the case
of Lhx2, the nearest genes were induced in eN, but not in eA (Fig-
ures 4D–4I). Similarly, putative Runx2 and Brn1 sites showed
elevated H3K27ac only in lA and lN, respectively (Figures 4J
and 4K; Figures S4J–S4O). In keeping with this, the genes near-
est to these Runx2 andBrn1 sites were significantly induced in IA
and lN, respectively (Figures 4L–4O). In addition, by comparing
the sites putatively occupied by Nfia, Atf3, and Runx2 at all
H3K27ac peaks throughout astrogliogenesis, we observed eA
stage-specific H3K27ac enrichment at Nfia and Atf3 motifs
and lA stage-specific H3K27ac enrichment at the Runx2 motif
(Figure S4P). Consistent with our previous observations, Nfia,Atf3, and Runx2 sites were already primed during the preceding
stage, before they acquired H3K27ac in eA and lA, respectively
(Figures 4A, 4B, and 4J). Altogether, our data suggest that
Nfia, Atf3, and Runx2 are crucial for switching the chromatin
state of their putative target elements from primed to active,
thereby driving the gene expression program underlying astro-
cyte differentiation and maturation.
Nfia, Atf3, and Runx2 Mediate Gene Expression
Programs Underlying Astrogliogenesis
To further investigate the target genes that are under the direct
transcriptional control of Nfia, Atf3, and Runx2, we performed
transcriptome profiling (RNA-seq) after performing an siRNA-
mediated depletion of these TFs at the eA stage (Nfia and Atf3)
or the lA stage (Runx2). Our analysis revealed a large number
of differentially expressed genes after their depletion (Figures
5A–5C; Table S1). Depletion of Nfia and Atf3 led to changes in
astrocyte morphology, as well as downregulation in astroglial
markers, such as Gfap, Aldh1l1, Aldoc, and Aqp4, while Runx2
knockdown resulted in the downregulation of genes such as
Nfia, Cx43, and Aqp4, but not of other markers, such as Gfap,
which was even upregulated, suggesting a potential role for
Runx2 in preventing a reactive state (Figure 5D; Figures S5A
and S5B). While Nfia depletion had no effect on proliferation,
apoptosis, or cell cycle (Figures S5C–S5E), Atf3 and Runx2
knockdown reduced apoptosis (Figures S5C–S5E) and Runx2-
depleted cells exhibited G0/G1 arrest (Figures S5C–S5E).
The genes that were downregulated or upregulated after the
Nfia depletion exhibited enrichment in extracellular matrix orga-
nization- and neuronal differentiation-related GO, respectively,
suggesting that Nfia may repress the neurogenesis-related pro-
gram (Figure 5E). However, genes that were downregulated or
upregulated after the Atf3 knockdown were enriched with terms
related to cell adhesion or mitotic cell-cycle processes, respec-
tively, implying that these genes are relevant for exiting the cell
cycle and entering astrocyte differentiation (Figure 5F). In
contrast, after Runx2 depletion, the downregulated genes were
enrichedwith GO terms related to cell morphogenesis and differ-
entiation, while the upregulated genes were enriched with genes
related to cytokine response, suggesting that Runx2 promotes
differentiation and may counteract acquisition of a reactive
phenotype (Figure 5G). Single-gene examples substantiated
our observations that Nfia and Atf3 promote astrogliogenesis
by suppressing neurogenesis and promoting cell-cycle exit of
progenitors, respectively, while Runx2 counteracts activation
of a reactive phenotype to promote astrocyte maturation (Fig-
ures 5H–5J). Genes that were downregulated upon Nfia, Atf3,
and Runx2 depletion were upregulated during astrogliogenesis,
corroborating the specific role of these TFs in astrogliogenesis
(Figures S5F–S5H). In addition, the genes downregulated upon
Nfia and Atf3 knockdown are expressed at a higher level in astro-
cytes compared to neurons, and an opposite pattern was
observed for the upregulated genes (Figures S5I and S5J). We
did not observe differential expression in astrocytes versus neu-
rons in the case of Runx2-deregulated genes (Figure S5K).
To determine whether the regulatory landscape of the deregu-
lated genes is also altered following TF depletion, we assessed
H3K27ac enrichment at stage-specific regulatory sites nearest
to these genes (Atf3 and Nfia for eA and Runx2 for lA). InCell Stem Cell 23, 557–571, October 4, 2018 563
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Figure 4. Distinct TF-Target Regulatory Elements Are Stage- and Lineage-Specifically Activated during Astrogliogenesis versus
Neurogenesis
(A–C) Heatmaps depicting the enrichment of H3K27ac and H3K4me1 during stages of either astroglial or neuronal differentiation at the genomic locations of the
Nfia (A), Atf3 (B), and Lhx2 (C) motifs within the scope of unique eA, in the cases of Nfia and Atf3, and eN, in the case of the Lhx2, H3K27ac peaks, including the
promoters.
(D–I) Expression of the genes nearest to and within 50 kb of the sites depicted in (A)–(C) in astroglial (D, F, and H) and neuronal (E, G, and I) differentiation (log2-
normalized read counts).
(J and K) Same as (A)–(C) except for the Runx2 and Brn1motif sites within the scope of the lA and lN H3K27ac unique peaks, respectively, including the promoter.
(L–O) Same as (D)–(I) except for the Runx2 and Brn1 motif sites within the scope of the lA and lN unique H3K27ac peaks, respectively, including the promoter.
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Figure 5. Astroglial TFs Regulate Distinct Gene Expression Programs during Astrogliogenesis
(A–C) Volcano plots depicting the differential expression of genes between the control conditions and the conditions with depletion of Nfia in eA (A), Atf3 in eA (B),
and Runx2 in lA (C) (green, up- and downregulated; black, no change).
(D) Bar plots representing the expression of astroglial markers (Gfap, Nfia, Aldh1l1, Aldoc, Aqp4, and Cx43) under the control and depleted conditions. Values are
plotted as normalized read counts.
(E–G) Heatmap depicting the top gene ontologies enriched with downregulated (marked in red) and upregulated (marked in green) genes upon Nfia knockdown
(E) and Atf3 knockdown (F) in eA and Runx2 knockdown (G) in lA.
(H–J) Examples of genes upregulated upon depletion of Nfia (H), Atf3 (I), and Runx2 (J).
(K–M) Profile plot of H3K27ac enrichment under the control conditions and the conditions with depleted Nfia (K), Atf3 (L), and Runx2 (M) in the regulatory regions
(H3K27ac peaks near deregulated genes) of the upregulated genes and downregulated genes upon Nfia and Atf3 reduction in eA and Runx2 reduction in lA.each case, downregulated genes lost H3K27ac enrichment
upon knockdown of these factors, indicating that these TFs
have an activating function at these sites (Figures 5K–5M).
Strikingly, in the case of upregulated genes, H3K27ac enrich-
ment at their regulatory sites did not change for Atf3 andRunx2 and only slightly increased for Nfia, suggesting that the
activation of these genes was likely a result of secondary
cascades. Overall, our data suggest that Nfia, Atf3, and Runx2
are critical for mediating the gene expression programs underly-
ing astrogliogenesis.Cell Stem Cell 23, 557–571, October 4, 2018 565
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Figure 6. Nfia, Atf3, and Runx2 Directly Bind Predicted Target Elements and Induce Chromatin Accessibility
(A) Motif enrichment analysis of the set of commonly deregulated and H3K27ac-enriched genes (47 genes) upon Nfia and Atf3 depletion.
(B–E) ChIP-qPCR following Nfia, Atf3, and Runx2 ChIP to detect the Nfia and Atf3 co-occupied (B), Nfia (C), Atf3 (D), and Runx2 (E) binding at predicted Nfia, Atf3,
and Runx2 motif sites in the candidate regulatory regions. Enrichments are plotted as a ratio of precipitated DNA (bound) to total input DNA and then further
normalized to an intergenic region.
(F–I) qPCR following ATAC in aNPC, eA, and lA and after Atf3 and Nfia (F; eA), Nfia (G; eA), Atf3 (H; eA), and Runx2 (I; lA) depletion at regulatory regions listed in
(B)–(E), depicted as a heatmap. Enrichments are plotted as in (B)-(E).Nfia, Atf3, and Runx2 Directly Bind Predicted Target
Elements and Induce Chromatin Accessibility
Given the known cooperativity among TFs that control cell-fate
decisions, we assessed whether Nfia and Atf3 collaborate to
regulate early astrogliogenesis. A comparison of the transcrip-
tome data after Nfia and Atf3 knockdown revealed a significant
overlap among the genes that were downregulated after their
depletion (n = 198 genes), suggesting similar aberrations in the
astrogliogenesis program after their knockdown (Figure S6A;
Table S5). Based on H3K27ac enrichment, a significant set of
genes that were commonly downregulated after Nfia and Atf3
depletion exhibited binding sites for both TFs (n = 47/198), sug-
gesting their potential direct cooperativity during astrocyte dif-
ferentiation (Figure 6A; Figure S6A).
Given our findings that Nfia, Atf3, and Runx2 are crucial for
switching the chromatin state of distal regulatory elements
from primed to active, we next investigated whether these fac-
tors bind the predicted target elements at the respective stages
of astrogliogenesis. Toward this end, we reanalyzed our data-
sets to validate the reduction in expression and H3K27ac enrich-
ment at selected target genomic loci following depletion of these
TFs (Figures S6B–S6I) Next, ChIP assays for Nfia and Atf3 in eA
and Runx2 in lA to demonstrated binding at the selected target
sites (Figures 6B–6E).566 Cell Stem Cell 23, 557–571, October 4, 2018Finally, we investigated whether the target sites of these TFs
gain in accessibility while they are bound by these TFs and
whether this increase in accessibility depends on the presence
of these factors. Assay for transposase-accessible chromatin
(ATAC) showed that these sites become more open in the corre-
sponding stages concomitant to TF binding and acquisition of
H3K27ac (Figures 6F–6I; Figures S6J–S6M). Conversely,
following depletion of these TFs, these target sites showed a sig-
nificant reduction in chromatin accessibility (Figures 6F–6I; Fig-
ures S6N–S6Q). Together with our previous observations, these
data support the notion that Nfia, Atf3, and Runx2 directly target
distal regulatory elements and induce their active state, as
manifested by increased chromatin accessibility, to drive gene
expression programs underlying the differentiation and matura-
tion of astrocytes.
Nfia, Atf3, or Runx2 Overexpression Steers Neurogenic
Radial Glia Away from Generating Neurons and
Promotes Astroglial Progenitor Generation In Vivo
To corroborate our key observations on astrogliogenesis from
ESCs, we employed primary cortical astrocytes from postnatal
day 5 (P5) mice to analyze occupancy by the astrogliogenic
TFs identified here and the occurrence of active chromatin land-
scape at defined target sites (Figure 7A). Primary astrocytes
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Figure 7. Astroglial TFs Regulate a Similar Set of Sites in Primary Cultures, and Their Overexpression In Vivo Alters the Fate of Cortical
Progenitors
(A) Schematic representation of primary astrocyte culture.
(B–E) ChIP-qPCR following H3K27ac ChIP in primary astrocytes derived from P5mice to detect its enrichment at the Nfia and Atf3 co-occupied (B), Nfia (C), Atf3
(D), and Runx2 (E)motif sites in the candidate regulatory regions. Enrichments are plotted as a ratio of precipitated DNA (bound) to total input DNA and then further
normalized to an intergenic region.
(legend continued on next page)
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exhibited high levels of H3K27ac at the identified TF-target reg-
ulatory elements (Figures 7B–7E). Further analysis using ChIP
assays for Nfia, Atf3, and Runx2 confirmed the occupancy by
these TFs at their predicted sites (Figures 7F–7I).
Given that these TFs were found to function in activation of as-
troglial-specific regulatory elements but were not engaged in
activation of similar elements in neurogenesis, we hypothesized
that the expression of these factors might interfere with the
execution of neurogenesis programs during embryonic develop-
ment. We thus performed in utero electroporation (IUE) of mouse
cortical progenitors on embryonic day (E) 15.5 (Figueres-On˜ate
et al., 2016; Pataskar et al., 2016) with plasmids encoding
NFIA, ATF3, or RUNX2 or a mixture of these three TFs (MIX) (Fig-
ures S7A and S7B). The successful expression of the TFs was
confirmed in HEK293T cells by immunoblotting (Figure S7C).
At E18.5, cells electroporated with the control plasmid exhibited
a typical distribution in the developing cortex that is character-
ized by migration to the cortical plate (CP) (54.8% ± 5.8% of
red fluorescent protein (RFP)-positive cells in the CP, n = 3 ani-
mals) (Figures 7J and 7K). In contrast, most cells overexpressing
each of the astrogliogenic TFs or their mixture failed to populate
the CP (Figures 7J and 7K). Instead, these cells were retained in
the GLAST-positive progenitor zone (Figures 7J and 7K; Fig-
ure S7D; Table S6). Furthermore, to evaluate whether the cells
ectopically expressing these TFs are prevented from acquiring
a neurogenic fate, we analyzed the expression of SATB2, a
marker of upper-layer neurons generated at this embryonic
stage, in electroporated cells (Figure 7L; Figure S7E; Table S6).
This analysis demonstrated that cells expressing any of these
TFs alone or in combination fail to gain expression of SATB2,
in line with their retention below the CP. Further analysis of the
expression of the astroglial progenitor marker SOX9 in electro-
porated cells showed that the expression of these TFs causes
neurogenic radial glia to generate a larger proportion of SOX9-
positive progenitors (Figure 7L; Table S6).
To characterize the influence of the TFs at a later stage of
development, we performed in utero electroporation in E15.5
cortical progenitors using MIX and analyzed at the P5 stage.
Consistent with our results at E18.5, TF-overexpressing cells
were mostly retained in the progenitor zone at P5, although
most control-electroporated cells generated neuronal cells that
already populated the upper cortical layers (Figure 7M). More-
over, we observed a significant increase in the number of
SOX9-positive cells among TF-electroporated cells compared
to control (Figures 7M and 7N; Table S6). In contrast, a converse
pattern was observed for themature neuronal marker NeuN (Fig-
ures 7M and 7N; Table S6). Altogether, these results suggest an(F–I) ChIP-qPCR following Nfia (F andG), Atf3 (F andH), andRunx2 (I) ChIP in prima
plotted as in B-E.
(J) Distribution of electroporated cells at the E18.5 stage upon in utero electrop
pCIDRE plasmid or pCIDRE plasmid encoding NFIA, ATF3, RUNX2, or a comb
white cells).
(K) Quantification of (J).
(L) Percentage of SOX9- and SATB2-positive cells among RFP-positive cells from
TFs or in combination) and analyzed at the E18.5 stage.
(M) Tilescan images showing distribution of electroporated cells at the P5 stage
with MYC). Representative images of SOX9, MYC, and NeuN immunofluorescen
(N) Quantification of SOX9 and NeuN in electroporated cells in the MIX condition. M
MIX condition.
568 Cell Stem Cell 23, 557–571, October 4, 2018increase in the generation of astroglial progenitors at the
expense of neurons.
DISCUSSION
We aimed to identify key regulators of astrogliogenesis based on
lineage- and stage-specific remodeling of the transcriptional and
epigenetic landscapes during astrocyte differentiation. Using
mouse ESC differentiation into astrocytes as a model system,
we identified three transcriptionally and epigenetically distinct
stages: (1) a progenitor stage (aNPC), (2) an early stage of astro-
glial differentiation (eA), and (3) a more advanced stage of astro-
glial differentiation (lA). We obtained evidence for epigenetic
priming along the differentiation axis, indicating that astroglio-
genesis follows a dynamic trajectory during which subsequent
stages are being orchestrated by preceding ones. By searching
for lineage- and stage-specific regulatory elements unique to
each stage and inferring their most highly associated TF binding
motifs, we were able to pinpoint drivers of the underlying differ-
entiation trajectory: the TFs Nfia, Atf3, and Runx2. These TFs
were found to be not only important for expression and mainte-
nance of astroglial marker genes but also critically required for
the epigenetic remodeling at the transition between distinct
stages. Our molecular analysis of astrogliogenesis supports
the notion that differentiation of neural precursors into astrocytes
is not a one-step but rather a multi-phase process (Kang et al.,
2012). Furthermore, in vivo overexpression of these TFs together
resulted in an increase in SOX9-positive progenitors at the
expense of neurogenesis; however, because of the transient na-
ture of the overexpression, a definitive cell fate could not be
tracked. It is possible that the continuous expression of the
TFs hampers proper astrocyte development and maturation,
and using a system allowing temporally controlled TF expression
could further drive the acquisition of an astrocytic phenotype.
A substantial body of prior work has provided compelling ev-
idence for an important role of Nfia at the onset of astrogliogen-
esis, both in the developing spinal cord and in the cerebral cortex
(Cebolla and Vallejo, 2006; Deneen et al., 2006; Kang et al.,
2012). However, the precise role of Nfia remains largely elusive.
Combined expression of Nfia with Nfib and Sox9 can induce
conversion of fibroblasts into astrocyte-like cells (Caiazzo
et al., 2015), supporting the notion of an instructive role in astro-
gliogenesis. The present study showed that Nfia is required for
converting primed chromatin into a transcriptionally active one
at the transition from aNPC to eA. Nfia also appears to play
an important role in suppressing neuronal gene expression.
Thus, Nfia may regulate distinct neuronal-fate-suppressing andry astrocytes derived fromP5mice, showing their occupancy. Enrichments are
oration of E15.5 ventricular and/or subventricular progenitors using a control
ination of all three factors (MIX) (revealed by RFP immunolabeling, shown as
cortices electroporated with pCIDRE control or pCIDRE-TF plasmids (single
following in utero electroporation as above in control or MIX condition (tagged
t staining in control and MIX conditions.
YC was used to quantify the expression of SOX9 in electroporated cells in the
astrocyte-fate-instructing gene expression modules. The latter
module may be co-regulated by Atf3, because there was signif-
icant overlap of genes, comprising putative shared direct tar-
gets, that were downregulated following knockdown of either
TF. Moreover, Nfia became downregulated following Atf3
knockdown, indicating that Atf3 may function upstream of Nfia.
Like Nfia, Atf3 was found to be crucial for the conversion
of primed to active chromatin. However, in contrast to Nfia,
knockdown of Atf3 resulted in the upregulation cell-cycle-
related genes, supporting a specific role of Atf3 in cell-cycle
exit at the progenitor stage. So far, Atf3 has been largely recog-
nized as a stress response gene (Hai et al., 1999). Stress
response such as unfolded protein response (UPR) mediated
by Atf4, itself known to induce Atf3, has been shown to regulate
the stage-specific balance between direct and indirect neuro-
genesis from radial glia during cortical development (Laguesse
et al., 2015), thus setting a precedent for ATF-mediated cell-
fate decisions. Finally, a study identified Drosophila Atf3 as a
cell polarity response gene. While there is ample evidence
for an important role for cell polarity in the regulation of
neuronal-fate decisions (Donohoe et al., 2018), virtually nothing
is known regarding the acquisition of a glial fate. Our study
warrants further investigation into the functional importance of
UPR and cell polarity regulation as potential mechanisms in
astrogliogenesis.
Virtually nothing is known about Runx2 function in the CNS
(Wang and Stifani, 2017). Runx2 plays a key role in osteoblast
and chondrocyte differentiation (Komori, 2018). Computational
modeling of stem cell-fate decisions predicted Runx2 as a deter-
minant of astrogliogenesis, and Runx2 overexpression induced
astroglial differentiation in mouse neural stem cells (Okawa
et al., 2016). One particularly intriguing observation was that
knockdown of Runx2 resulted in the induction of genes associ-
ated with reactive astrocytes, suggesting that Runx2 may be
important in repressing a reactive phenotype. Reactive astro-
gliosis represents in many respects a state of dedifferentiation
and involves reacquisition of neural stem cell properties (Robel
et al., 2011), which can eventually reactivate neurogenic poten-
tial (Magnusson et al., 2014; Nato et al., 2015). It will be
interesting to learn whether such dedifferentiation involves
downregulation of Runx2.
Consistent with its known function in astrogliogenesis (Bonni
et al., 1997; Moon et al., 2002), Stat3 was found to strongly influ-
ence astroglial marker expression following knockdown. Sur-
prisingly, however, we failed to observe global changes in
H3K27ac at its putative targets. Although we cannot exclude
that Stat3 may induce chromatin remodeling via alternative
mechanisms, such as sequence-independent recruitment of
Stat3, our observation may genuinely indicate that Stat3 acts
by transactivating already-accessible targets upon prior chro-
matin remodeling by pioneer TFs. Given its role in opening chro-
matin at the transition to the lA stage, Runx2 might be in a prime
position to exert such a function. However, activation of Stat3 is
also implicated in reactive astrogliosis (Herrmann et al., 2008);
hence, Runx2 and Stat3 may act partially antagonistically to
each other.
Although our study revealed compelling evidence for dynamic
transcriptional and epigenetic remodeling during astrogliogene-
sis, it also raises intriguing questions regarding the molecularmechanisms that account for the epigenetic writing of specific
priming marks at gene loci that subsequently become specif-
ically activated in astrogliogenesis. Furthermore, how the TFs
driving astrogliogenesis are activated during this process re-
mains to be investigated. Lastly, we lack molecular insights
into how the TFs mediate transition of the chromatin state of
the target regulatory elements from primed to active. Decipher-
ing these mechanisms will lead us to a better understanding of
how glial and neuronal lineage diverge during development.
Our study represents a rich resource for the identification and
characterization of further regulators of such key decisions dur-
ing CNS development.
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Antibodies
Name Company Catalog #
Rabbit polyclonal AQP4 Santa Cruz Biotechnology sc-20812; RRID:AB_2274338
Rabbit polyclonal ATF3 (C-19) Santa Cruz sc-188; RRID:AB_2258513
Rabbit polyclonal ATF3 (EPR19488) Abcam ab207434; RRID:AB_2734728
Mouse monoclonal beta III-tubulin Sigma T8660; RRID:AB_477590
Rat monoclonal CD44 BD PharMingen 550538; RRID:AB_393732
Rabbit polyclonal Connexin 43 Abcam ab11370; RRID:AB_297976
Guinea pig polyclonal DCX Millipore AB2253; RRID:AB_1586992
Mouse monoclonal FLAG (M2 clone) Sigma F1804; RRID:AB_262044
Mouse polyclonal GAPDH Abcam ab9484; RRID:AB_307274
Mouse monoclonal GFAP Sigma G3893; RRID:AB_477010
Rabbit polyclonal GFAP Dako Z0334(29-2); RRID:AB_10013382
Rabbit polyclonal GLAST Frontier Institute AB_2571715; RRID:AB_2571715
Rabbit polyclonal H3K4me1 Abcam ab8895; RRID:AB_306847
Rabbit polyclonal H3K27ac Abcam ab4729; RRID:AB_2118291
Rat Monoclonal ASCL1 R&D Systems MAB2567; RRID:AB_2059503
Mouse polyclonal MYC Cell Signaling 2276; RRID:AB_331783
Rabbit polyclonal NESTIN BioLegend 839801; RRID:AB_2565443
Mouse polyclonal NeuN Millipore MAB377; RRID:AB_2298772
Rabbit polyclonal Nf-1A (K-21) Santa Cruz sc-133816; RRID:AB_10611351
Rabbit polyclonal NFIA Abcam ab41851; RRID:AB_944419
Rabbit polyclonal OLIG2 Millipore AB9610; RRID:AB_570666
Rabbit polyclonal RFP Biomol 600401379S; RRID:AB_11182807
Rabbit polyclonal Runx2 (M-70) X Santa Cruz sc-10758X; RRID:AB_2184247
Rabbit polyclonal S100 Abcam ab868; RRID:AB_306716
Mouse polyclonal S100-beta Abcam ab11178; RRID:AB_297817
Rabbit polyclonal SATB2 Abcam ab34735; RRID:AB_2301417
Rabbit polyclonal SOX9 Abcam ab185966; RRID:AB_2728660
HRP anti-Goat IgG Santa Cruz SC-2020; RRID:AB_631728
Alexa Fluor 488 goat anti-mouse IgG Invitrogen A11001; RRID:AB_2534069
Alexa Fluor 488 donkey anti-mouse IgG Invitrogen A21202; RRID:AB_141607
Alexa Fluor 568 goat anti-mouse IgG Invitrogen A11004; RRID:AB_141371
Alexa Fluor 633 goat anti-mouse IgG Invitrogen A21050; RRID:AB_141431
Alexa Fluor 647 donkey anti-mouse IgG Invitrogen A31571; RRID:AB_162542
HRP anti-mouse IgG Santa Cruz SC-2005; RRID:AB_631736
Alexa Fluor 488 goat anti-rabbit IgG Invitrogen A11008; RRID:AB_143165
Alexa Fluor 488 donkey anti-rabbit IgG Invitrogen A21206; RRID:AB_141708
Alexa Fluor 568 goat anti-rabbit IgG Invitrogen A11011; RRID:AB_143157
Donkey IgG anti-Rabbit IgG (H+L)-Cy3 Dianova 711-165-152; RRID:AB_2307443
Alexa Fluror 633 goat anti-rabbit IgG Invitrogen A21070; RRID:AB_2535731
Alexa Fluor 647 donkey anti-rabbit IgG Invitrogen A31573; RRID:AB_2536183
HRP anti-rabbit IgG Santa Cruz SC-2004; RRID:AB_631746
Alexa Fluor 633 goat anti-rat IgG Invitrogen A21094; RRID:AB_141553
DAPI Sigma D9542; Sigma CAS# 28718-90-03
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Bacterial and Virus Strains
DH5a Competent Cells Invitrogen 18265017
One Shot TOP10 Chemically Competent E. coli Invitrogen C404010
Chemicals, Peptides, and Recombinant Proteins
1 Kb ladder NEB N3232S
100 bp ladder NEB N3231S
100x Glutamax Invitrogen 35050-0380
10x Antractic Phos run Buffer NEB B0389 S
1-Bromo-3-Chloropropane Sigma B9673
1M Hydrochloric acid Applichem A1434.1000
2-Mercaptoethanol Sigma M3148-100ML
2-Propanol Sigma I9516-500ML
Acrylamide AppliChem A 1672
Agar Merck 1119251000
Agarose Lonza 98200-100
Ammonium persulfat Amresco M133-100 g
Ampicillin Sigma A5354-10 ml
Ampicillin Sodium Salt AppliChem 4G017739
Annexin V BD Biosciences 559934
Antrarctic Phosphase NEB M0289S
Aqua-poly mount Polysciences 18606-20
B27 supplement Life Technologies 17504-044
BioRad protein assay GIBCO 500-0006
BrdU Sigma B5002-100MG
Bromphenol-blue Merck 1.08112.0025
BSA(Cell culture) Sigma A9418-50 g
Chloroform Sigma C2432
Chloroform: Isoamyl alcohol 24:1 Sigma C0549-1PT
Deoxycholic Acid Sodium salt Amresco 0613-100G
DEPC water Roth K028.2
Dimethylsulfoxide Sigma D8418
DMEM GIBCO 21969-035
DMEM-F12 GIBCO 21331-020
DNase I, RNase free 1000U EN0525
Donkey serum Merck Milipore S30-100ml
dNTP mix NEB N0447S
Baytril (Enrofloxacin) Baytril Bayer
EGF PeproTech AF-100-15-1 mg
EGTA Sigma E0396
Ethanol absolute Sigma 34923
Ethidium bromide Sigma 46065
Ethylene glycol Sigma 324558
Ethylenediamine tetraacetic acid Disodiumsalt (EDTA) Calbiochem 15576-028/324503
FBS Invitrogen 10270-106
FGF-2 PeproTech 100-18B-100 ug
Formaldehyde Sigma F8775-500ML
Gelatin Sigma G1890-100 g
Glucose Sigma G8270
Glycerol 99% Sigma G5516-500ML
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Glycine Merck 8.16013.1000
Glycogen Roche 10901393001
HEPES acid free Amresco 0511-250G
HEPES potassium salt Sigma H0527
Isoflurane Isova vet, Centauro 240055
Kanamycin sulfate Sigma 60615-5 g
L-Glutamax Invitrogen 35050-0380
LIF N/A Self-made
Lipofectamine 2000 Invitrogen 11668-019
Lipofectamine RNAiMAx Invitrogen 13778-0150
Lithium chloride VWR 437032G
Magnesium chloride anhydrous Sigma M8266
Meloxicam VITA Laboratories N/A
Methanol Sigma 34860-2.5L-R
Milkpowder (skim) Merck 1.15363.0500
N,N,N’,N’, Tetramethylethylenediamine Sigma T9281-50ML
N2 supplement Life Technologies 17502-048
Natural mouse laminin Invitrogen 23017-015
Neurobasal medium GIBCO 21103-049
N-Lauroylsarcosine sodium salt Sigma L9150
Non-essential amino acids GIBCO 1140-035
Nonidet P 40 substitute Sigma 74385-1L
Oregon Green 488 BAPTA Life Technologies O6807
Opti-MEM GIBCO 31985-047
Paraformaldehyde Merck 8.18715.1000
PBS pH 7.2 (10x) 500 ml 70013-016
Pen/Strep, 10000u/ml Invitrogen 15140122
Phenol solution Sigma P4557-100 ml
Phenylmethanesulfonyl fluoride Amresco 0754-5G
Poly-l-ornithine hydrobromide BD Biosciences P3655-100 mg
Ponceau-solution Sigma P7170-1L
Potassium hydroxide, granular Merck 1050330500
Propidium iodide Sigma P4170-10 mg
Protease inhibitor mix 100x GE healthcare 80-6501-23
Protein A Agarose beads Millipore 16-156
Protein G Agarose beads Millipore 16-266
Proteinase K Sigma P2308-25mG
Purple loading dye NEB B7024 S
Quick Ligation kit NEB M2200S
Rbcl2 Sigma 83980-10 g
Rimadyl Carprofen Pfizer N/A
RNase Applichem A3832,0050
RNase away Sigma 83931
Rneasy MiniElute spin columns QIAGEN 1026497
S2-0.5% Trypsin-EDTA GIBCO 15400-054
Saponin VWR 440914Y
SDS-20% Merck 428018-200ML
SeaBlue Protein Standard Life Sciences LC5925
di-Sodium tetraborate Decahydrat Merck 1.01964.0025
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Sodium azide Sigma S2202
Sodium bicarbonate Applichem A0384
Sodium chloride Amresco 0241-1KG
Sodium fluoride Merck 1.06449.0250
Sodium hydroxide VWR 28244295
Sodium orthovanadate Alfa Aesor E11W016
Sodium Pyruvate Sigma P2256
Sybr Green Invitrogen 4367659
T4 DNA Ligase NEB M0202S
T4 DNA Ligase Buffer NEB B0202S
T4 DNA polymerase NEB M0203S
Taq DNA Polymerase NEB M0267S
tert.-Butanol Sigma 308250-1L
Thermo Pol Buffer NEB B9004S
Tri reagent Sigma T9424-100 ml
Tris Ultrapure Invitrogen 15504-020
Tris-Hydrochloride CalBiochem 648317
Triton x 100 Sigma X100-1L
tRNA Sigma R5636-1 ml
Trypan blue GIBCO 15250-061
Trypsin-EDTA, 0.5% Life Technologies 15400054
Trypton Soy Agar Merck 1.05458.0500
Tryptone Sigma (Fluka) T9410-250 g
Tween 20 Sigma P1379-500ML
Vectashield mounting media Vector H-1000
Critical Commercial Assays
High Capacity cDNA RT kit Invitrogen 4368814
Nextera DNA Library Prep Kit Illumina FC-121-1030
Power Sybr Green PCR Master Mix Life Technologies 4367659
Deposited Data
RNA-seq during astrogliogenesis and upon
TF depletion
This study GEO: GSE96539
H3K27ac ChIP-seq during astrogliogenesis and
upon TF depletion
This study GEO: GSE96539
H3K4me1 ChIP-seq during astrogliogenesis This study GEO: GSE96539
Experimental Models: Cell lines
ESCs ATCC SCRC-1002; RRID:CVCL_5746
Experimental Models: Organisms/Strains
C57BL/6J The Jackson Laboratory Jax#000664; RRID:IMSR_JAX:000664
Oligonucleotides
See Table S7 for primer sequences This study N/A
See Table S7 for siRNAs sequences Dharmacon N/A
Recombinant DNA
pCIDR-dsRed Pataskar et al., 2016 N/A
pCIDR-Nfia-dsRed This Study N/A
pCIDR-Atf3-dsRed This Study N/A
pCIDR-Runx2-dsRed This Study N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
ImageJ NIH N/A; RRID:SCR_003070
ZEN Carl Zeiss Microscopy N/A; RRID:SCR_013672
FACSCanto II using DIVA software BD Biosciences N/A; RRID:SCR_001456
HCImage software Hamamatsu Corporation N/A; RRID:SCR_015041
Prism Graphpad N/A; RRID:SCR_005375
TopHat v.2.0.8 JHU (Trapnell et al., 2009) N/A; RRID:SCR_013035
SAMTOOLS v0.1.19 University of Birmingham (Li et al., 2009) N/A; RRID:SCR_002105
HTSeq program v0.5.4p1 Python package (Anders et al., 2015) N/A; RRID:SCR_005514
DESeq Bioconductor (Oshlack et al., 2010) N/A; RRID:SCR_000154
ToppGene Cincinnati Children’s Hospital Medical
Center (Chen et al., 2009)
N/A; RRID:SCR_005726
pheatmap R package R package N/A; RRID:SCR_016418
Bowtie v0.12.9 JHU (Langmead, 2010) N/A; RRID:SCR_016368
QuasR package Bioconductor (Gaidatzis et al., 2015) N/A; RRID:SCR_006820
MACS v2.0.10.20120913 Liu’s Lab (Zhang et al., 2008) N/A; RRID:SCR_013291
ngs.plot.r program (Shen et al., 2014) N/A; RRID:SCR_011795
HOMER v4.7 HOMER N/A; RRID:SCR_010881
findMotifs.pl program HOMER N/A; RRID:SCR_016417CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resource/reagents should be directed to and will be fulfilled by the Lead Contact, Prof. Dr. Ben-
edikt Berninger (benedikt.berninger@kcl.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The handling of the mice and all experimental procedures were conducted in accordance with the European Union guidelines on the
use andwelfare of experimental animals (2010/63/EU). Experimental procedures were approved by the State of Rheinland Pfalz, Ger-
many (23177-07/G17-1-067) or Spanish Ministry of Agriculture (RD 1201/2005 and L 32/2007) and the Cajal Institute, CSIC Animal
Experimentation Ethics Committees and the Community of Madrid (Ref. PROEX 223/16). Animals were housed on a 12:12 hr light-
dark cycle, with free access to food and water. None of the mice used were involved in previous procedure or drug treatment. Both
male and female embryos were used and randomly allocated to experimental groups.
Cell culture
mESCs derived fromC57/BL-6 mice were cultured in DMEM supplemented with 10% FBS, 2mMGlutamax, 2 mM sodium pyruvate,
2 mM non-essential amino acids, Leukemia-inhibitory factor (LIF) and 50 mM b-mercaptoethanol. The cell medium was changed
every day, and the cells were passaged every second day using 0.05% trypsin and plated on 0.2% gelatin coated plates. Using
the protocol proposed by Conti et al., the ESCs were further differentiated into aNPC (Conti et al., 2005; Pollard et al., 2006). Briefly,
the ESCs were passaged and grown in N2/B27 media containing 0.5x DMEM-F12, 0.5x N2 supplement, 0.5x B27 supplement, 0.5x
Neurobasal media, 2mMGlutamax and 2mMPenicillin-Streptomycin for 7 days on 0.2%gelatin coated plates. The cells were trypsi-
nized and grown on uncoated dishes for the following 7 days in NSA media containing 10 ng/ml FGF2 and 10 ng/ml EGF to form cell
aggregates. The formed aggregates were further passaged and grown on 0.2%Gelatin coated plated to obtain the monolayer of the
aNPC. To generate the astrocytes, the aNPC were differentiated in differentiation media containing DMEM, 1% FBS, 1x B27, LIF,
2 mM Glutamax and 2 mM Penicillin-Streptomycin for 1, 5 and 21 days. For differentiation of aNPC into neurons, cells were kept
in neurobasal media, along with B27 for 2 weeks. 293T cells were cultured in DMEM, 10% FBS, Penicillin-Streptomycin and
Glutamax.
Primary astrocyte culture
The primary astrocyte culture was prepared from the brains of P5-P7 C57/BL6 mice using a previously described protocol (Heinrich
et al., 2011). Briefly, the cortices were dissected to remove the white matter and meninges and cultured in DMEM-F12 media sup-
plemented with 1x B27, 10% FBS, 2 mM Glutamax and 2 mM Penicillin-Streptomycin.e5 Cell Stem Cell 23, 557–571.e1–e8, October 4, 2018
METHOD DETAILS
Immunofluorescence and Brdu labeling
The cells were grown on coverslips, fixedwith 4%paraformaldehyde and permeabilizedwith 0.2%Triton X-100 for 5minutes at room
temperature. Subsequently, the cells were blocked with 5% BSA for 30 minutes, incubated with primary antibodies (mouse anti-
GFAP-1:500, G3893, Sigma; rabbit anti-GFAP-1:200, Z0334(29-2), DAKO; rabbit anti-AQP4-1:200, sc-20812, Santa Cruz; mouse
anti-S100B, ab11178, Abcam; rabbit anti-GLAST-1:200, AB_2571715, Frontier Institute; rabbit anti-CX43-1:200, ab11370, Abcam;
rabbit anti-OLIG2-1:200, AB9610, Milipore; rat anti-ASCL1-1:200, MAB256, R&D systems; rabbit anti-NES-1:200, 839801,
BioLegend; anti-guinea pig anti-DCX-1:200, AB2253, Milipore; rabbit anti-SOX9-1:200, ab185966, Abcam and rat anti-CD44-
1:200, 550538, BD PharMingen) for 1 hour, and then incubated with a fluorochrome-labeled secondary antibody for 45 minutes at
room temperature. The coverslips were counterstained with DAPI and imaged under a confocal laser-scanning microscope. The
data were processed using Adobe Photoshop software. For the Brdu labeling, the aNPC were differentiated into astrocytes for 1
and 5 days, labeled with 30 mM Brdu for 8 hours. Cells were fixed in 70% ethanol and denatured by using 2N HCL/0.5% Triton
X-100 for 30 minutes. HCL was neutralized by 0.1 M Na2B4O7 pH 8.5 buffer for 2 minutes. Cells were washed with 0.5%Tween-
20/1% BSA/PBS buffer before proceeding for Brdu staining (1:200, B5002, Sigma) as above.
Immunoblotting
Immunoblotting was performed as described previously (Tiwari et al., 2013) using following antibodies: mouse anti-GFAP (1:1000,
G3893, Sigma), rabbit anti-CX43 (1:000, ab11370, Abcam), rat anti-ASCL1 (1:1000, MAB2567, R&D systems), rabbit anti-NES
(1:1000, 839801, BioLegend), rabbit anti-OLIG2 (1:1000, AB9610, Milipore), rabbit anti-NFIA (1:1000, ab41851, Abcam), rabbit
anti-RUNX2 (1:1000, sc-10758 X, Santa Cruz), rabbit anti-GAPDH (1:1000, ab9484, Abcam) and mouse anti-FLAG (1:1000,
F1804, Sigma). Briefly, cells were lysed using RIPA buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM EGTA, 1.5 mM MgCl2,
1% Glycerol, 1% Triton X-100) and protein concentration was measured using Biorad reagent (Life Technologies) following manu-
facturer’s protocol. 50 mg lysate was mixed with final 1x Laemelli buffer (5x Laemelli buffer: 10% SDS, 50% glycerol, 25% 2-mercap-
toethanol, 0.02%bromphenol blue and 0.3125MTris HCl, pH approx. 6.8.), then run at 150 V and transferred at 100 V for 2-hourswith
BioRad Mini-PROTEAN and Mini Trans-Blot Cell tanks respectively. Subsequently, the membranes were blocked with 5% non-fat
dry milk in TBST for 1 h at room temperature and incubated in primary antibodies diluted in 5% non-fat dry milk in TBST for overnight
at 4C. The membranes were washed three times for 5 minutes with TBST and incubated in horseradish peroxidase coupled sec-
ondary antibody (in 5% non-fat dry milk) for 1 hour at room temperature. After three 5 minutes washes with TBST, membranes
were incubated with ECL solution (Amersham ECLTM Prime Western Blotting Detection Reagent) according to the manufacturer’s
instructions and imaged with the Peqlab Fusion-SL system using the fusion software version 15.16 by Vilber Lourmat.
Ca2+ Imaging
eA and lA were incubated with 10 mM OGB1, diluted in culture medium, for 45 min at 37C in a humidified atmosphere. After the in-
cubation time, cells were washedwith warm culturemedia and analyzedwithin 2 hr (Lee et al., 2015). Cells were placed in a recording
chamber mounted on a fluorescent microscope (Zeiss Axio Imager A2) and superfused with artificial cerebrospinal fluid (ACSF) (in
mM): NaCl, 125; KCl, 2.5; NaHCO3, 25; NaH2PO4, 1.25; CaCl2, 2; MgCl2, 1 and glucose, 25, saturated with 5% CO2 and 95% O2
(pH 7.4, 30-32C). Cells were visualized with a 40x (0.7 NA) objective and movies (15 s) were acquired with a frequency of 8.9 Hz
with a Hamamatsu Orca-0.3G camera and HCImage software (Lee et al., 2015). During acquisition, we tested the generation of
Ca2+waves in astrocytes usingmechanical stimuli with a glass pipette whichwas placed right above themembrane of cultured astro-
cyte (resistance of 5-10MU, which corresponds to a tip opening of 1-2mm) (Lee et al., 2015). For quantification, we defined regions of
interest (ROIs) in cells surrounding the site of mechanical stimulus. Intensity measurements for ROIs are expressed as the change of
fluorescence relative to background fluorescence (DF/F0) and were calculated with ImageJ (ROI manager) (Lee et al., 2015).
siRNA transfection and plasmid transfection
For the siRNA (Dharamcon) transfection, Lipofectamine RNAiMax (Invitrogen) was used according to manufacturer’s instructions to
knockdown the candidate TFs. The candidates were first knocked down in aNPC for 2 days to reduce the basal level expression
and were then re-transfected with siRNA at day 0 and kept in aNPC media for 1 day and changed to astromedia next day for 1 day
experiment (Nfia and Atf3). On the other hand, for the 5 days experiment (Runx2), day 2 astrocytes were re-transfected with siRNA in
astrocyte differentiation media. 293T cells were transfected with pCIDR-dsRed or pCIDR-TF-dsRed plamids by using Lipofectamine
2000, according to manufacturer’s instructions.
RNA purification, cDNA preparation and Quantitative RT-PCR
RNAwas extracted using the Tri-reagent from sigma, and cDNA was prepared according to the manufacturer’s instructions (Applied
Biosystems) using 1 mg of initial RNAmaterial. The cDNA was used to quantify the gene expression on a StepOne plus real-time PCR
machine. The primer sequences are provided in Table S7.Cell Stem Cell 23, 557–571.e1–e8, October 4, 2018 e6
Chromatin Immunoprecipitation
The ChIP experiments were performed as previously described (Tiwari et al., 2013). In brief, crosslinked chromatin was sonicated to
achieve an average fragment size of 500 bp. Starting with 60 mg of chromatin and 5 mg of the anti-H3K27ac (Abcam), anti-Nfia (Santa
Cruz), anti-Atf3 (Santa Cruz) and anti-Runx2 antibodies (Santa Cruz), the samples were immunoprecipitated and then de-crosslinked
to release the DNA fragments. In total, 1 mL of the ChIP material and 1 mL of the input material were used for the quantitative real-time
PCR using specific primers covering the motifs of Nfia, Atf3 and Runx2 in eA and lA. Primers covering an intergenic region were used
as a control. The efficiencies of the PCR amplification were normalized to the PCR product of the intergenic region. Primer sequences
provided in Table S7.
Transcriptome analysis
The transcriptome samples under the astroglial differentiation (aNPC, eA and lA), control and TF knockdown conditions (GSE96539)
were derived in triplicate for astroglial differentiation and in biological replicates for depletion studies. The RNaseq output in FASTQ
format was subjected to an initial quality assessment using FASTQC v2.6.14. After the quality check, the files were used for the read
alignment to the mouse genome (mm9) with UCSC annotations (Karolchik et al., 2014) using TopHat v.2.0.8 (Trapnell et al., 2009);
then, the uniquelymapped reads were retained in the output BAM file. SAMTOOLS v0.1.19 (Li et al., 2009) was used for the file format
conversions and sorting of the alignment file. The raw read counts per gene were calculated using HTSeq program v0.5.4p1 (Anders
et al., 2015), and the read count data matrix was then subjected to library-size normalization and differential expression analyses
using DESeq (Oshlack et al., 2010). An FDR cutoff of 0.1 was used to call the differentially expressed genes. The transcriptomes
from the in vitro astroglial differentiation were normalized together, while those from the control and TF KDwere normalized indepen-
dently. The GO term analysis of all gene lists (Gene Symbol) was performed using ToppGene (Chen et al., 2009). Heatmaps depicting
the gene expression were plotted using pheatmap R package. The analyzedmicroarray data fromGSE9655 (Cahoy et al., 2008) were
directly downloaded from GEO, while the RNaseq data from GSE73721 (Zhang et al., 2016) were analyzed as described above
and compared to the RNaseq data using a linear regression analysis. Gene lists derived from the RNaseq analysis are supplied in
Table S1.
ChIP-seq and motif analysis
The ChIP-sequencing output in FASTQ format was subjected to a quality check using FASTQC v2.6.14 (Andrews). ChIP-seq was
performed to detect the histone markers H3K27ac and H3K4me1 during each stage of astroglial differentiation (GSE96539) and
H3K27ac under the control and shortlisted TF knockdown conditions. Bowtie v0.12.9 (Langmead, 2010) was used to align the reads
uniquely, i.e., each read was maximally aligned to one position, to mm9 genome with UCSC annotations (Karolchik et al., 2014). The
alignment output files from two biological replicates were merged together after checking for correlations across the replicates using
the SAMTOOLS v0.1.19 (Li et al., 2009) merge function. SAMTOOLS v0.1.19 (Li et al., 2009) was used for the alignment file format
conversions and sorting of alignment output files. The WIGGLE files for the alignment files were generated using QuasR package
(Gaidatzis et al., 2015). The peaks were computed without providing input with MACS v2.0.10.20120913 (Zhang et al., 2008) using
the default parameters. The enrichment was calculated using formula as previously described (Pataskar et al., 2016). The heatmaps
and the density plots representing the ChIP-seq normalized read distribution over the shortened genomic region were plotted using
the ngs.plot.r program (Shen et al., 2014).
HOMER v4.7 was used to obtain annotation information for the peaks, including the distance to the nearest TSS and the nearest
gene. The peaks were associated with their nearest genes if they were either intergenic and less than 50KB from the TSS or at pro-
moters, intron and exons.
A motif analysis was performed by HOMER v4.7 using a GC% normalized background control on the shortlisted genome coordi-
nate sets using the findMotifs.pl program. Motif scanning of the complete genome was performed using the scanMotifsGenome.pl
program in HOMER v4.7.
ATAC
ATAC library preparation was performed exactly as described (Buenrostro et al., 2013). Briefly, 50,000 eA and lA cells were incubated
with 0.1%NP-40 to isolate nuclei. Nuclei were then transposed for 30min at 37Cwith adaptor-loadedNextera Tn5 (Illumina, Fc-121-
1030). Transposed fragments were directly PCR amplified and used for qRT-PCR.
Cell growth assay
For growth curves, cells were seeded in each well of a 24-well plate and cell numbers were assessed over the time periods indicated
by using a Neubauer counting chamber upon TF depletion. For cell cycle analysis, cells were trypsinized and fixed overnight in 70%
ice-cold ethanol, washed twice with PBS, and resuspended in sodium citrate buffer with 5 mg/ml PI overnight. Stained cells were
analyzed on a FACSCanto II using DIVA software.
Apoptosis assay
Apoptosis assays were performed using a Cy5 Annexin V antibody according to the manufacturer’s instructions (BD Biosciences).
Stained cells were filtered with a 40mm mesh and analyzed on a FACSCanto II flow cytometer using DIVA software.e7 Cell Stem Cell 23, 557–571.e1–e8, October 4, 2018
In utero electroporation
E15.5 pregnant C57BL/6 mice were anesthetized with 1.5%–2.8% isoflurane (Isova vet, Centauro) in pure O2 and received an injec-
tion of enrofloxacin (5 mg/kg, s.c.; Baytril Bayer) and meloxicam (300 mg /kg, s.c.; VITA Laboratories)/ Rimadyl (carprofen; 5 mg/kg;
Pfizer) before starting the surgical procedure. The surgical area was constantly maintained moistened with a physiological saline
solution. The abdominal cavity was opened, and the uterine horns were carefully extracted. For each embryo, 1 mL of DNA solution
was injected into the lateral ventricle using a glass capillary, and 5 consecutive electric pulses of 37 V (50 ms each, 950 ms intervals)
were delivered through platinum electrodes (3 mm diameter) using a BTX electroporator (Holliston). The uterine horns were then re-
placed in the abdominal cavity, and the abdomen was sutured. The DNA consisted of a pCAG-IRES-dsRedexpress (pCIDRE; 4 mg)
(Pataskar et al., 2016) plasmid as control, or encoding NFIA, ATF3 or Runx2.
Immunohistochemistry and image analysis
For the in utero electroporated brains analyzed at E18.5, the pregnantmicewere sacrificed, and the embryoswere extracted from the
uterine horns. For analysis at postnatal stages, animals were perfused with a saline solution (NaCl 0,9% in PB 0,1M) followed by 4%
paraformaldehyde (PFA). Harvested embryonic brains were placed in 4% PFA for 48 h for fixation and postnatal brains were post-
fixed in 4% PFA for 24 h. The brains were embedded in agarose (3%, in PBS) and cut into 50 or 70 mm (for postnatal and embryonic
brains, respectively) serial coronal sections using a vibrating microtome (Microm HM650V, Thermo Scientific). The sections were
then stored in a cryoprotective solution (20% glucose, 40% ethylene glycol, 0.025% sodium azide, and 0.05 M phosphate buffer,
pH 7.4). For immunohistochemistry, free-floating sections were incubated for 90 min at room temperature (RT) in a blocking solution
(5% Donkey serum, 0.3% Triton X-100 in TBS 0.1 M, pH 7.6). The primary antibodies, which were diluted in blocking solution, were
applied for 2 hours at RT and overnight at 4C. The following antibodies were used: donkey anti-RFP (1:500, 600401379S, Biomol) to
detect the pCIDRE-electroporated cells, rabbit anti-SOX9 (1:200, ab185966, Abcam), rabbit anti-SATB2 (1:200, ab34735, Abcam),
mouse anti-TUBB3 (1:500, T8660, Sigma), rabbit anti-GLAST (1:300, AB_2571715, Frontier Institute), mouse anti-MYC tag (1:200,
2276S, Cell signaling), andmouse anti-NeuN (1:500,MAB377,Milipore). The appropriate secondary antibodies were diluted in block-
ing solution and applied for 1 hour at room temperature. The sections were then counterstained with DAPI and mounted with Vecta-
shield (Vector Laboratories) mountingmedium. Image stacks were acquired under an SP5 confocal microscope (Leica) with a 20x dry
objective (NA 0.7) or a 40x oil objective (NA 1.3). For Figure 7M, tilescans showing the dispersion pattern of RFP +ve cells were ac-
quired under an SP5 confocal microscope (Leica) with a 40x oil objective (NA 1.3). Output 2D images were generated in ImageJ using
the Maximum Intensity Projection (MIP) method. The quantification of the distribution of the electroporated cells was performed in 3
animals/group (n = 3) with 2 sections/brain.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was evaluated by One-Way ANOVA, followed by Dunnett’s test for multiple group comparisons or by t test
for 2-groups comparison, using the SPSS Statistics 22 software for Figures 7, S1, S5, and S7. P values represent * < 0.05;
** < 0.01; *** < 0.001. The data are expressed as themean ± SD. The number of experiments and biological samples used is specified
in figure legends and Star Methods. The bar plots were generated using Prism software.
DATA AND SOFTWARE AVAILABILITY
All relevant data are available from authors. All the software used in this work are described in the relevant Star Methods sections.
RNA-seq and ChIP-seq data have been deposited (GEO: GSE96539).Cell Stem Cell 23, 557–571.e1–e8, October 4, 2018 e8
